Immunocore Holdings Ltd Capital Reinvestment Ratio
Immunocore Holdings Ltd capital reinvestment ratio. Immunocore Holdings Ltd (IMCR) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow ($25.96 Million) in capital expenditures ($414.00K). See how much free cash does Immunocore Holdings Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Immunocore Holdings Ltd (2013–2024)
Capital reinvestment ratio of Immunocore Holdings Ltd from 2013 to 2024. This chart tracks Immunocore Holdings Ltd's Capital Reinvestment Ratio across 4 annual periods. See IMCR financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Immunocore Holdings Ltd Capital Reinvestment Ratio by Year (2013–2024)
Immunocore Holdings Ltd capital reinvestment ratio by year from 2013 to 2024. For the full cash flow conversion analysis, see IMCR cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.20x | $26.06 Million | $5.17 Million | ▼ -89.2% |
| 2023 | 1.85x | $2.33 Million | $4.29 Million | ▲ +3518.2% |
| 2014 | 0.05x | $39.79 Million | $2.03 Million | ▼ -0.8% |
| 2013 | 0.05x | $11.26 Million | $579.08K | — |